Technical Analysis for MGNX - MacroGenics, Inc.

Grade Last Price % Change Price Change
grade B 27.42 -0.07% -0.02
MGNX closed down 0.07 percent on Friday, August 7, 2020, on 57 percent of normal volume. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up
Historical MGNX trend table...

Date Alert Name Type % Chg
Shooting Star Candlestick Bearish 0.00%
20 DMA Support Bullish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Doji - Bearish? Reversal 0.00%
BB Squeeze + Upper Band Touch Range Contraction 0.00%
Upper Bollinger Band Touch Strength 0.00%
Crossed Above 20 DMA Bullish -0.07%
MACD Bullish Centerline Cross Bullish -0.07%
Bollinger Band Squeeze Range Contraction -0.07%
Inside Day Range Contraction -0.07%

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

MacroGenics is a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer and autoimmune diseases. The company generates its pipeline of product candidates from its proprietary suite of next-generation antibody technology platforms, which it believes improve the performance of monoclonal antibodies and antibody-derived molecules. The company creates both differentiated molecules that are directed to novel cancer targets, as well as "bio-betters," which are drugs designed to improve upon marketed medicines. The combination of MacroGenics' technology platforms and antibody engineering expertise has allowed the company to generate promising product candidates and enter into several strategic collaborations with global pharmaceutical and biotechnology companies.
Medicine Biotechnology Biopharmaceutical Cancer Life Sciences Biology Immunology Treatment Of Cancer Antibodies Immune System Autoimmune Diseases Monoclonal Antibodies Antibody Technology Platforms Novel Cancer

Is MGNX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 32.18
52 Week Low 4.04
Average Volume 907,666
200-Day Moving Average 14.28
50-Day Moving Average 25.93
20-Day Moving Average 26.97
10-Day Moving Average 26.53
Average True Range 1.79
ADX 18.07
+DI 28.52
-DI 16.50
Chandelier Exit (Long, 3 ATRs ) 26.49
Chandelier Exit (Short, 3 ATRs ) 29.33
Upper Bollinger Band 29.06
Lower Bollinger Band 24.88
Percent B (%b) 0.61
BandWidth 15.51
MACD Line 0.07
MACD Signal Line 0.11
MACD Histogram -0.0405
Fundamentals Value
Market Cap 1.01 Billion
Num Shares 36.8 Million
EPS -4.19
Price-to-Earnings (P/E) Ratio -6.54
Price-to-Sales 56.93
Price-to-Book 2.96
PEG Ratio 0.01
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 30.84
Resistance 3 (R3) 31.05 30.13 30.27
Resistance 2 (R2) 30.13 29.26 30.02 30.08
Resistance 1 (R1) 28.77 28.72 28.31 28.56 29.89
Pivot Point 27.85 27.85 27.62 27.74 27.85
Support 1 (S1) 26.49 26.98 26.03 26.28 24.95
Support 2 (S2) 25.57 26.44 25.46 24.76
Support 3 (S3) 24.21 25.57 24.57
Support 4 (S4) 24.00